Mindfulness Walking Intervention to Enhance Resilience (iWalk)
iWalk
A Randomized Controlled Trial of a Walking Meditation Intervention (iWalk) to Enhance Resilience in Adults
1 other identifier
interventional
90
1 country
1
Brief Summary
This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS). The objectives are to evaluate:
- 1.Recruitment capability and retention rates,
- 2.Acceptability and adherence to the intervention,
- 3.Feasibility of assessment procedures, and
- 4.Preliminary effects on psychological, physiological, and behavioral outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
October 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
December 16, 2025
December 1, 2025
4.6 years
October 16, 2025
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Connor Davidson Resilience Scale for Adults (CD-RISC 25)
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.
Multiple Sclerosis Resilience Scale (MSRS)
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.
Stroop Task
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.
Symbol Digit Modalities Test
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.
Wisconsin Card Sorting Test
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.
Sustained Attention to Response Task
The baseline means assessments done two weeks before the intervention start date. Post-intervention assessments will be conducted two weeks after the intervention. Follow-up 1 is 24 weeks from baseline, and follow-up 2 is 48 weeks from baseline.
Study Arms (3)
iWalk Program
ACTIVE COMPARATORThis group receives the complete iWalk program.
Education Only without Walking Mindfulness Practice
ACTIVE COMPARATORThis group receives only education part of the iWalk program without walking mindfulness sessions.
Control Group
NO INTERVENTIONThis group does not receive any intervention and are placed on a waiting list.
Interventions
A multi-component behavioral program integrating walking meditation, education, and group sessions to enhance resilience and stress regulation in adults with and without chronic conditions.
Eligibility Criteria
You may qualify if:
- years or older,
- clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.,
- have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs,
- never received meditation training via coaching/certification/life coaching,
- have internet access,
- with no severe cognitive impairment, i.e., have a score of ≥ 21 on Modified Telephonic Interview for Cognitive Status (TICS-M),
- be able to walk with or without an assistive device (Patient determined Disease Steps score ranged from 0-6),
- are willing to be randomized to an intervention or a control group,
- are willing to wear Fitbit (a wrist smart watch) for eight weeks,
- are individuals who are right-handed according to the Edinburgh Handedness Questionnaire,
- are willing to participate in all assessments, including in-person testing using electroencephalography (EEG) and cognitive tests, online survey/questionnaires, and online interviews or focus group discussions,
- are willing to wear a Hexoskin t-shirt, which is a heart rate variability monitor, while doing the assessments in person.
You may not qualify if:
- Participants who cannot speak, read, write, or listen in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois Urbana-Champaign
Urbana, Illinois, 61801, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 16, 2025
First Posted
December 16, 2025
Study Start
June 1, 2025
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
December 16, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share